High frequency of decreased antithrombin level in pregnant women with thrombosis

International Journal of Hematology

Volumn 102, Issue 3, 2015, Pages 253-258

  Kamimoto, Yuki ^a   Wada, Hideo ^a   Ikejiri, Makoto ^b   Nakatani, Kaname ^a   Sugiyama, Takashi ^c   Osato, Kazuhiro ^a   Murabayashi, Nao ^a   Yamada, Norikazu ^a   Matsumoto, Takeshi ^a   Ohishi, Kohshi ^a   Ishikawa, Hidehiro ^a   Tomimoto, Hidekazu ^a   Ito, Masaaki ^a   Ikeda, Tomoaki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AT; PC; Pregnancy; Thrombophilia; Thrombosis

Indexed keywords

ANTITHROMBIN; PROTEIN C; PROTEIN S; ANTITHROMBIN GLASGOW;

ADULT; ANTITHROMBIN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CONGENITAL DISORDER; FEMALE; GENETIC ANALYSIS; HEMOSTASIS; HETEROZYGOTE; HUMAN; PREGNANT WOMAN; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; THROMBOSIS; YOUNG ADULT; AGED; BLOOD; COMPARATIVE STUDY; GENETICS; MALE; METABOLISM; PREGNANCY; PREGNANCY COMPLICATION; PROTEIN C DEFICIENCY; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN PROTEINS; ANTITHROMBINS; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTEIN C DEFICIENCY; VENOUS THROMBOEMBOLISM;

EID: 84941261578     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-015-1822-0     Document Type: Article

References (31)

1. Franchini M. Haemostasis and pregnancy. Thromb Haemost. 2006;95:401–13.
2. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16:153–68.
3. Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol. 2015;125:5–12.
4. Martinelli I. Thromboembolism in women. Semin Thromb Hemost. 2006;32:709–15.
5. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case-control study. Am J Obstet Gynecol. 2008;198:233–7.
6. James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29:326–31.
7. Conard J, Horellou MH, van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost. 1990;63:319–20.
8. Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors. Arterioscler Thromb Vasc Biol. 1996;16:742–8.
9. Friederich PW, Sanson BJ, Simioni P, Zanardi S, Hilsman MV, Girolami A, ten Cate JW, Prins MH. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med. 1996;125:955–60.
10. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342:374–80.
11. MacCallum P, Bowles L, Keeling D. Diagnosis and management of heritable thrombophilias. BMJ. 2014;17(349):g4387.
12. Guimicheva B, Czuprynska J, Arya R. The prevention of pregnancy-related venous thromboembolism. Br J Haematol. 2015;168:163–74.
13. Nelson-Piercy C, MacCallum P, Mackillop L, on behalf of the Guidelines Committee of the Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. RCOG Green-top Guideline 2009; No. 37a. London: Royal College of Obstetricians and Gynaecologists; 2009.
14. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194:1311–5.
15. Liu S, Rouleau J, Joseph KS, Sauve R, Liston RM, Young D, Kramer MS. Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada. J Obstet Gynaecol Can. 2009;31:611–20.
16. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–30.
17. Ikejiri M, Shindo A, Ii Y, Tomimoto H, Yamada N, Matsumoto T, Abe Y, Nakatani K, Nobori T, Wada H. Frequent association of thrombophilia in cerebral venous sinus thrombosis. Int J Hematol. 2012;95:257–62.
18. Olds RJ, Lane DA, Caso R, Panico M, Morris HR, Sas G, Dawes J, Thein SL. Antithrombin III Budapest: a single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family. Blood. 1992;79:1206–12.
19. Sakuragawa N, Takahashi K, Kondo S, Koide T. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis. Thromb Res. 1983;31:305–17.
20. Thein SL, Lane DA. Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT—TGT) and antithrombin III Glasgow (393 CGT—CAT). Blood. 1988;72:1817–21.
21. Miyata T, Zheng YZ, Sakata T, Tsushima N, Kato H. Three missense mutations in the protein C heavy chain causing type I and type II protein C deficiency. Thromb Haemost. 1994;71:32–7.
22. Miyata T, Sakata T, Zheng YZ, Tsukamoto H, Umeyama H, Uchiyama S, Ikusaka M, Yoshioka A, Imanaka Y, Fujimura H, Kambayashi J, Kato H. Genetic characterization of protein C deficiency in Japanese subjects using a rapid and nonradioactive method for single-stand conformational polymorphism analysis and a model building. Thromb Haemost. 1996;76:302–11.
23. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood. 1994;83:683–90.
24. Galambosi PJ, Ulander VM, Kaaja RJ. The incidence and risk factors of recurrent venous thromboembolism during pregnancy. Thromb Res. 2014;134:240–5.
25. Tanaka H, Katsuragi S, Osato K, Hasegawa J, Nakata M, Murakoshi T, Yoshimatsu J, Sekizawa A, Kanayama N, Ishiwata I, Ikeda T. Increase in maternal death-related venous thromboembolism during pregnancy in Japan (2010–2013). Circ J. 2015;79:1357–62.
26. Shindo A, Wada H, Ishikawa H, Ito A, Asahi M, Ii Y, Ikejiri M, Tomimoto H. Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients. Int J Hematol. 2014;99:437–40.
27. Terni E, Giannini N, Chiti A, Gialdini G, Orlandi G, Montano V, Orsucci D, Brondi M, Bonuccelli U, Mancuso M. Cerebral sinus venous thrombosis: clinical and pathogenetic perspectives from Tuscany. Blood Coagul Fibrinolysis. 2015 [Epub ahead of print].
28. Hasegawa M, Wada H, Wakabayashi H, Yoshida K, Miyamoto N, Asanuma K, Matsumoto T, Ohishi K, Shimokariya Y, Yamada N, Uchida A, Sudo A. The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery. Clin Chim Acta. 2013;425:109–13.
29. Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014;123:1674–80.
30. Suzuki A, Sanda N, Miyawaki Y, Fujimori Y, Yamada T, Takagi A, Murate T, Saito H, Kojima T. Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. J Biol Chem. 2010;285:13444–53.
31. Habe K, Wada H, Ito-Habe N, Suzuki H, Nobori T, Mizutani H. Two patients with antiphospholipid antibody developed disseminated intravascular coagulation. Intern Med. 2013;52:269–72.